[1] ItoY, Hosono K, Amano H. Responses of hepatic sinusoidal cells to liver ischemia-reperfusion injury[J]. Front Cell Dev Biol, 2023,11(1):1171317. [2] MachadoIF, Palmeira CM, Rolo AP. Preservation of mitochondrial health in liver ischemia/reperfusion injury[J]. Biomedicines, 2023,11(3):948. [3] 钱子冰,张琦,曾佩芸,等. 肝窦内皮细胞-肝脏的守门员[J]. 海南医学院学报,2022,28(4):315-320. [4] 姜婷婷,胡媛,曹建平. 肝窦内皮细胞在肝损伤中的功能研究进展[J]. 中国血吸虫病防治杂志,2023,35(1):92-97. [5] WangT, Fang Y, Zhang X, et al. Heme oxygenase-1 alleviates ischemia-reperfusion injury by inhibiting hepatocyte pyroptosis after liver transplantation in rats[J]. Front Biosci (Landmark Ed), 2023,28(10):275. [6] TianX, Wang Y, Yuan M, et al. Heme Oxygenase-1-Modified BMMSC activate AMPK-Nrf2-FTH1 to reduce severe steatotic liver ischemia-reperfusion injury[J]. Dig Dis Sci, 2023,68(11):4196-4211. [7] 戴伟明,陆伦根,蔡晓波. 肝窦内皮细胞与肝纤维化的关系[J]. 临床肝胆病杂志,2023,39(2):419-423. [8] 房志强,阮柏,刘晶晶,等. 肝血窦内皮细胞介导的他莫昔芬对非酒精性脂肪性肝炎治疗作用的转录组学分析[J]. 现代生物医学进展,2022,22(9):1609-1613. [9] 罗昕,蔡晓波,陆伦根. 肝窦内皮细胞介导的细胞串扰在肝纤维化中的作用[J]. 肝脏,2022,27(12):1263-1265. [10] 孙睿,李涛,任万华. 肝窦内皮细胞损伤在肝窦阻塞综合征发生进程中的作用:聚焦免疫炎性机制的研究进展[J]. 中华肝脏病杂志,2024,32(3):279-283. [11] LiX, Wu L, Tian X, et al. miR-29a-3p in exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells alleviates steatotic liver ischemia-reperfusion injury in rats by suppressing ferroptosis via iron responsive element binding protein 2[J]. Oxid Med Cell Longev, 2022,22(1):6520789. [12] LiJJ, Dai WQ, Mo WH, et al. Fucoidan ameliorates ferroptosis in ischemia-reperfusion-induced liver injury through Nrf2/HO-1/GPX4 activation[J]. J Clin Transl Hepatol, 2023,11(6):1341-1354. [13] ZuoH, Wang Y, Yuan M, et al.Small extracellular vesicles from HO-1-modified bone marrow-derived mesenchymal stem cells attenuate ischemia-reperfusion injury after steatotic liver transplantation by suppressing ferroptosis via miR-214-3p[J]. Cell Signal, 2023,109(1):110793. [14] 袁博,明廷凤,瞿思铭,等. 血红素加氧酶-1对肝窦内皮细胞增殖及促肝再生表型的影响[J]. 中华肝胆外科杂志,2022,28(7):536-541. [15] 马晓飞,焦彦如,张俊杰. 栀子苷对肝脏缺血再灌注损伤大鼠炎症反应、氧化应激和PI3K/Akt信号通路的影响[J]. 现代药物与临床,2023,38(1):29-36. [16] 邓银芝,倪利华. 肝脏缺血再灌注损伤的机制及防治策略的研究进展[J]. 微循环学杂志,2023,33(2):109-115. [17] XiaoX, Liu D, Chen S, et al. Sevoflurane preconditioning activates HGF/Met-mediated autophagy to attenuate hepatic ischemia-reperfusion injury in mice[J]. Cell Signal, 2021,82(1):109966. [18] SalehH, El-Shorbagy HM. Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2/Bax, TNF-α and TGF-β expression[J]. Int J Biol Macromol, 2020,164(1):1565-1574. [19] MorsyMA, Ibrahim YF, Abdel Hafez SMN, et al. Paeonol attenuates hepatic ischemia/reperfusion injury by modulating the Nrf2/HO-1 and TLR4/MYD88/NF-κB signaling pathways[J]. Antioxidants (Basel), 2022,11(9):1687. [20] YounisNS, Abdelnaby RM, Mohamed ME. Hepatoprotective effects of linalool against liver ischemia-reperfusion: the role of Nrf2/HO-1/NQO1 and TLR4/RAGE/NFκB pathways[J]. Eur Rev Med Pharmacol Sci, 2023,27(20):10094-10111. [21] TaoT, Ye B, Xu Y, et al. β-Patchoulene preconditioning protects mice against hepatic ischemia-reperfusion injury by regulating Nrf2/HO-1 signaling pathway[J]. J Surg Res, 2022,275(1):161-171. [22] WangS, Zeng X, Yang Y, et al. Hypothermic oxygenated perfusion ameliorates ischemia-reperfusion injury of fatty liver in mice via Brg1/Nrf2/HO-1 axis[J]. Artif Organs, 2022,46(2):229-238. [23] AliFF, Mohammed MM, Hussein Y, et al. Targeting PI3K/p-Akt/eNOS, Nrf2/HO-1, and NF-κB/p53 signaling pathways by angiotensin 1-7 protects against liver injury induced by ischemia-reperfusion in rats[J]. Cell Biochem Funct, 2024,42(1):e3938. |